Saringosterol
Saringosterol is an orally active steroid found in Sargassum muticum. Saringosterol is a LXR agonist. Saringosterol can lower cholesterol levels and inhibit the mRNA and protein expression of peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT enhancer-binding protein α (C/EBPα). Saringosterol has anti-obesity, anti-atherosclerosis, anti-Mycobacterium tuberculosis and anti-depressant activities.
For research use only. We do not sell to patients.
- CAS No.: 6901-60-6
- Formula: C29H48O2
- Molecular Weight:428.69
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
IC50 & Target
[1]|
PPARγ |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| J774 | IC50 |
>233.3 μM
Compound: 14
|
Cytotoxicity against mouse J774 cells by alamar blue assay
Cytotoxicity against mouse J774 cells by alamar blue assay
|
[PMID: 17637068] |
| Vero | IC50 |
>128 μg/mL
Compound: Saringosterol
|
Cytotoxicity against african green monkey Vero cells by celltiter 96 aqueous nonradioactive assay
Cytotoxicity against african green monkey Vero cells by celltiter 96 aqueous nonradioactive assay
|
[PMID: 11720535] |
In Vitro
Saringosterol (12.5-200 μM; 24 h) does not reduce the viability of 3T3-L1 cells[1].
Saringosterol (50-200 μM; 8 days) dose-dependently inhibits lipid and triglyceride accumulation in 3T3-L1 preadipocytes, with 200 μM reducing accumulation to 26.6% of control differentiated cells[1].
Saringosterol (50-200 μM; 24 h) dose-dependently increases glycerol release from 3T3-L1 adipocytes, with 200 μM inducing a statistically significant elevation[1].
Saringosterol (100-200 μM; 8 days) significantly reduces mRNA and protein expression of PPARγ and C/EBPα in 3T3-L1 cells[1].
Saringosterol (100-200 μM; 8 days) significantly reduces mRNA expression of adipogenic marker genes (aP2, adiponectin, resistin, and FAS) in 3T3-L1 cells[1].
Saringosterol (20 μM; 24 h) increases mRNA expression of LXR-regulated cholesterol transport/uptake genes (ABCA1, ABCG1, and IDOL) and reduces cellular cholesterol content in RAW264.7 macrophage-derived foam cells[2].
Saringosterol shows antitubercular activity of MIC of 0.25 μg/mL[3].
Saringosterol exhibits no appreciable toxicity against Vero cells, with an IC50 greater than 128 μg/mL[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDI-induced 3T3-L1 cells
-
Concentration:100, 200 μM
-
Incubation Time:8 days (from initiation of differentiation)
-
Result:Significantly inhibited mRNA expression of PPARγ and C/EBPα, with both concentrations showing statistically significant inhibition.
Significantly inhibited mRNA expression of aP2, adiponectin, resistin, and FAS, with both concentrations showing statistically significant inhibition.
-
Cell Line:MDI-induced 3T3-L1 cells
-
Concentration:100, 200 μM
-
Incubation Time:8 days (from initiation of differentiation)
-
Result:Significantly inhibited protein expression of PPARγ and C/EBPα, with both concentrations showing statistically significant inhibition.
In Vivo
Saringosterol (10-30 mg/kg; i.p., single dose 30 min before testing; 30 mg/kg; p.o., daily for 7 days) produces significant dose-dependent antidepressant-like effects in mouse behavioral despair models[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:ApoE−/− mice with a high-fat die with (8-week-old)[2]
-
Dosage:50 mg/kg
-
Administration:p.o.; daily; 2 weeks
-
Result:Reduced atherosclerotic plaque burden, with en face aortic plaque area (percentage of total aortic area) and aortic root cross-sectional plaque area significantly lower than control mice.
Significantly decreased serum total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels; significantly increased serum high-density lipoprotein cholesterol levels.
No significant change in liver total cholesterol levels; significantly reduced liver triglyceride levels compared to control mice.
Attenuated hepatic steatosis, with reduced liver weight and liver weight-to-body weight ratio compared to control mice; no upregulation of hepatic lipogenic genes (SREBP-1c, ACC, FASN, SCD1, chREBP).
Upregulated mRNA levels of cholesterol efflux transporters ABCA1 and ABCG1, and LDLR-degrading protein IDOL in peritoneal macrophages.
Upregulated hepatic mRNA levels of cholesterol catabolism enzyme CYP7A1, cholesterol efflux transporters ABCG5 and ABCG8, and HDL-cholesterol influx receptor SR-B1.
Downregulated intestinal mRNA levels of cholesterol absorption transporter NPC1L1; upregulated intestinal mRNA levels of cholesterol efflux transporters ABCG5, ABCG8, and ABCA1.
-
Animal Model:ICR (male, 20-22 g)[4]
-
Dosage:10 mg/kg; 20 mg/kg; 30 mg/kg (single dose; behavioral tests); 30 mg/kg (neurotransmitter analysis)
-
Administration:i.p (10-30 mg/kg); p.o.; daily for 7 days (30 mg/kg)
-
Result:Reduced immobility time in forced swim test and tail suspension test.
Did not significantly alter locomotor activity in open-field test at all tested doses.
Increased brain serotonin (5-HT) levels, 5-hydroxyindoleacetic acid (5-HIAA) levels and noradrenaline (NE) levels.
Showed no significant effect on brain dopamine (DA) levels.
Chemical Information
-
CAS No. 6901-60-6
-
Appearance Solid
-
Molecular Weight 428.69
-
Formula C29H48O2
-
Color White to off-white
-
SMILES
C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(C=C)(O)C(C)C)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4(C(C[C@H](CC4)O)=CC3)C
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Research Protocol for Cardiovascular Diseases
Cardiovascular disease can be modeled as maladaptive cardiac remodeling, where ischemic injury or pressure overload activates inflammatory signaling, fibroblast activation, extracellular-matrix deposition, cardiomyocyte hypertrophy, vascular remodeling, and progressive ventricular dysfunction. The TGF-β/SMAD axis is a central profibrotic pathway after myocardial injury and pressure overload, while innate immune and cytokine pathways regulate leukocyte recruitment, scar formation, and adverse remodeling. Key unresolved questions include which inflammatory signals are reparative versus harmful, when fibrosis is protective versus maladaptive, and whether pathway inhibition improves function without weakening necessary infarct healing or compensatory remodeling.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
-
Protocol For Protein Expression And Purification
Recombinant protein expression in Escherichia coli followed by purification of a His-tagged soluble protein by immobilized metal affinity chromatography (IMAC), with optional MBP fusion and TEV tag removal when the construct includes these elements. The biological readout is production of the encoded target protein, detected as an inducible band at the expected molecular mass by SDS-PAGE and quantified by total protein assay or chromatographic absorbance; the purification readout is enrichment of the target protein in elution fractions after selective binding of polyhistidine residues to immobilized Ni2+/metal-chelate resin and elution by imidazole-containing buffer. Expression is driven by an inducible bacterial expression system, commonly T7/lac-based, in which IPTG or lactose/auto-induction activates transcription and translation of the cloned gene; lower induction temperature, lower inducer concentration, induction timing, and solubility-enhancing fusion tags can influence the frac
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Lee JA, et al. Anti-Obesity Activity of Saringosterol Isolated from Sargassum muticum (Yendo) Fensholt Extract in 3T3-L1 Cells. Phytother Res. 2017 Nov;31(11):1694-1701. [Content Brief]
[2]. Yan Y, et al. Saringosterol from Sargassum fusiforme Modulates Cholesterol Metabolism and Alleviates Atherosclerosis in ApoE-Deficient Mice. Mar Drugs. 2021 Aug 26;19(9):485. [Content Brief]
[3]. Wächter GA, et al. Inhibition of Mycobacterium tuberculosis growth by saringosterol from Lessonia nigrescens. J Nat Prod. 2001;64(11):1463-1464. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)